Medication info
Misartan Twin Tablet 40/5 mg (Telmisartan, Amlodipine Besilate)

Misartan Twin Tablet 40/5 mg (Telmisartan, Amlodipine Besilate)

Prescription medicationOral
Ingredient · strength
Telmisartan›40mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
IYun Pharmaceutical Co., Ltd.
Appearance
Biconvex oval-shaped double tablet in white and light blue
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201900724 · Approved 2019.01.30 · Insurance code 658603650

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this drug. However, direct switching to this drug may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience (only for this drug 40/5 milligrams). ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
IYun Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension for whom blood pressure is not adequately controlled with monotherapy of telmisartan or amlodipine. It helps to lower blood pressure more effectively, reduce the risk of cardiovascular complications, and improve blood pressure control. Therefore, it is a suitable choice for treating essential hypertension.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the doses of the individual components (telmisartan or amlodipine) be adjusted before starting this drug. However, direct switching to this drug may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience (only for this drug 40/5 milligrams). ◦ Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication can seriously affect the fetus during pregnancy, particularly in the second and third trimesters; therefore, pregnant women or those who may become pregnant should not take it. It should not be administered to patients with certain conditions, such as severe liver disease, severe hypotension, cardiogenic shock, or unstable blood flow following acute myocardial infarction. Patients with impaired liver function or obstructive biliary disease may require dose adjustments and caution when using this medication. It may cause a sudden drop in blood pressure, so patients who are deficient in fluids or salts should stabilize their condition before taking it and follow medical advice. Due to the risk of hyperkalemia, blood potassium levels should be regularly monitored when taking potassium supplements or potassium-containing medications concurrently. Patients with heart failure or cardiovascular diseases may experience worsening symptoms while taking this medication; careful monitoring by a physician is necessary. Dizziness or drowsiness may occur; caution should be taken when driving or operating machinery. This medication may interact with other drugs, so if other medications are being taken, it is essential to consult a physician or pharmacist. Nursing mothers are advised not to take this medication. Overdose may lead to serious side effects such as hypotension, tachycardia, and renal failure; therefore, prescribed dosages must be strictly adhered to. Use in children and adolescents under 18 years of age is not recommended, as safety and efficacy have not been established. This medication should be kept out of reach of children and should only be opened immediately before administration.

Side effects

  • Dizziness
  • peripheral edema
  • fainting
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • sensory loss
  • taste alteration
  • tremor
  • extrapyramidal disorder
  • hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • intestinal air retention
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver dysfunction
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • itching
  • sweating
  • rash
  • alopecia
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • vascular edema
  • toxic skin eruption
  • drug rash
  • urticaria
  • polymorphic erythema
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urination disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • elevated liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light in. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius, avoiding very hot or cold areas.

Appearance and packaging

Appearance

Biconvex oval-shaped double tablet in white and light blue

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.